Publicacions en col·laboració amb investigadors/es de Centro Nacional de Biotecnología (10)

2023

  1. Cardiac Progenitor Cell Exosomal miR-935 Protects against Oxidative Stress

    Cells, Vol. 12, Núm. 18

  2. Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver

    Molecular Genetics and Metabolism Reports, Vol. 35

  3. Topoisomerase Inhibitors Increase Episomal DNA Expression by Inducing the Integration of Episomal DNA in Hepatic Cells

    Pharmaceutics, Vol. 15, Núm. 10

  4. Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice

    Aging Cell, Vol. 22, Núm. 3

2012

  1. Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of plasmodium

    PLoS ONE, Vol. 7, Núm. 4

2011

  1. Self-inactivating helper virus for the production of high-capacity adenoviral vectors

    Gene Therapy, Vol. 18, Núm. 11, pp. 1025-1033

2007

  1. Virus distribution of the attenuated MVA and NYVAC poxvirus strains in mice

    Journal of General Virology, Vol. 88, Núm. 9, pp. 2473-2478

2003

  1. Induction of Protective Immunity against Malaria by Priming-Boosting Immunization with Recombinant Cold-Adapted Influenza and Modified Vaccinia Ankara Viruses Expressing a CD8+-T-Cell Epitope Derived from the Circumsporozoite Protein of Plasmodium yoelii

    Journal of Virology, Vol. 77, Núm. 21, pp. 11859-11866

2001

  1. Protective immune response against cutaneous leishmaniasis by prime/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36/LACK and IL-12 in combination with purified p36

    Microbes and Infection, Vol. 3, Núm. 9, pp. 701-711

1997

  1. Cloning of the gp63 surface protease of Leishmania infantum. Differential post-translational modifications correlated with different infective forms

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1361, Núm. 1, pp. 92-102